Reproducibility, reliability and validity of population-based administrative health data for the assessment of cancer non-related comorbidities

PLoS ONE

Volumn 12, Issue 3, 2017, Pages

  Maringe, Camille ^a   Fowler, Helen ^a   Rachet, Bernard ^a   Luque Fernandez, Miguel Angel ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ALGORITHM; ARTICLE; CANCER MORTALITY; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COMORBIDITY ASSESSMENT; CONTROLLED STUDY; DATA EXTRACTION; EARLY CANCER DIAGNOSIS; HEALTH STATISTICS; HUMAN; MALIGNANT NEOPLASM; MEDICAL RECORD; POPULATION RESEARCH; RELIABILITY; REPRODUCIBILITY; VALIDITY; ENGLAND; FEMALE; HEALTH SURVEY; LONGITUDINAL STUDY; MALE; MORTALITY; NEOPLASMS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY;

ALGORITHMS; COMORBIDITY; ENGLAND; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; NEOPLASMS; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 85014732805     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0172814     Document Type: Article

References (49)

1. Sogaard M, Thomsen RW, Bossen KS, Sorensen HT, Norgaard M. The impact of comorbidity on cancer survival: a review. Clinical epidemiology. 2013; 5(Suppl 1):3-29. doi: 10.2147/CLEP.S47150 PMID: 24227920
2. Glymour MM, Mayeda ER, Selby V. Selection bias in clinical epidemiology: causal thinking to guide patient-centered research. Epidemiology. 2016.
3. Corkum M, Urquhart R, Kendell C, Burge F, Porter G, Johnston G. Impact of comorbidity and healthcare utilization on colorectal cancer stage at diagnosis: literature review. Cancer Causes & Control. 2012; 23 (2):213-20. doi: 10.1007/s10552-011-9875-8 PMID: 22101505
4. Fleming ST, Pursley HG, Newman B, Pavlov D, Chen K. Comorbidity as a Predictor of Stage of Illness for Patients With Breast Cancer. Medical care. 2005; 43(2):132-40. PMID: 15655426
5. Terret C, Castel-Kremer E, Albrand G, Droz JP. Effects of comorbidity on screening and early diagnosis of cancer in elderly people. The Lancet Oncology. 2009; 10(1):80-7. doi: 10.1016/S1470-2045(08) 70336-X PMID: 19111248
6. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of chronic diseases. 1987; 40(5):373-83. PMID: 3558716
7. Porta MS, Greenland S, Last JM, Oxford University Press., International Epidemiological Association. A dictionary of epidemiology. New York; Oxford: Oxford University Press,; 2008. http://www.oxfordreference.com/view/10.1093/acref/9780195314496.001.0001/acref-9780195314496.
8. Feinstein AR. The Pre-Therapeutic Classification of Co-Morbidity in Chronic Disease. Journal of chronic diseases. 1970; 23(7):455-68. PMID: 26309916
9. Sarfati D. Review of methods used to measure comorbidity in cancer populations: no gold standard exists. Journal of clinical epidemiology. 2012; 65(9):924-33. doi: 10.1016/j.jclinepi.2012.02.017 PMID: 22739245
10. Bannay A, Chaignot C, Blotiere PO, Basson M, Weill A, Ricordeau P, et al. The Best Use of the Charlson Comorbidity Index With Electronic Health Care Database to Predict Mortality. Medical care. 2016; 54(2):188-94. doi: 10.1097/MLR.0000000000000471 PMID: 26683778
11. Health and Social Care Information Centre. Hospital Episode Statistics. 2016 [cited 2016 11/10/2016]. http://content.digital.nhs.uk/hes.
12. Organization WH. International Statistical Classification of Diseases and Related Health Problem, 10th revision. 2010.
13. Health and Social Care Information Centre. OPCS-4 Classification. 2016. http://systems.digital.nhs.uk/data/clinicalcoding/codingstandards/opcs4.
14. Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. Journal of clinical epidemiology. 2004; 57 (12):1288-94. doi: 10.1016/j.jclinepi.2004.03.012 PMID: 15617955
15. Hernan MA, Hernandez-Diaz S, Robins JM. A structural approach to selection bias. Epidemiology. 2004; 15(5):615-25. PMID: 15308962
16. Rabe-Hesketh S, Skrondal A. Multilevel and longitudinal modeling using Stata. 3rd ed. College Station, Tex.: Stata Press Publication; 2012.
17. Weiss NS. Clinical epidemiology: the study of the outcome of illness. 3rd ed. Oxford; New York: Oxford University Press; 2006. ix, 178 p. p.
18. Bernardini J, Callen S, Fried L, Piraino B. Inter-rater reliability and annual rescoring of the Charlson comorbidity index. Advances in Peritoneal Dialysis. 2004; 20:125-7. PMID: 15384811
19. Imamura K, McKinnon M, Middleton R, Black N. Reliability of a comorbidity measure: the Index of Co- Existent Disease (ICED). Journal of clinical epidemiology. 1997; 50(9):1011-6. PMID: 9363035
20. German RR, Lee LM, Horan JM, Milstein RL, Pertowski CA, Waller MN, et al. Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. MMWRRecommendations and reports: Morbidity and mortality weekly report Recommendations and reports/Centers for Disease Control. 2001; 50(RR-13):1-35; quiz CE1-7.
21. Centers for Disease Control and Prevention. Guidelines for evaluating surveillance systems.MMWR supplements. 1988; 37(5):1-18. PMID: 3131659
22. Kehl KL, Lamont EB, McNeil BJ, Bozeman SR, Kelley MJ, Keating NL. Comparing a medical recordsbased and a claims-based index for measuring comorbidity in patients with lung or colon cancer. Journal of geriatric oncology. 2015; 6(3):202-10. doi: 10.1016/j.jgo.2015.01.005 PMID: 25662785
23. Sarfati D, Gurney J, Stanley J, Salmond C, Crampton P, Dennett E, et al. Cancer-specific administrative data-based comorbidity indices provided valid alternative to Charlson and National Cancer Institute Indices. Journal of clinical epidemiology. 2014; 67(5):586-95. doi: 10.1016/j.jclinepi.2013.11.012 PMID: 24582212
24. Sarfati D, Gurney J, Lim BT, Bagheri N, Simpson A, Koea J, et al. Identifying important comorbidity among cancer populations using administrative data: Prevalence and impact on survival. Asia-Pacific journal of clinical oncology. 2013.
25. Brewer N, Borman B, Sarfati D, Jeffreys M, Fleming ST, Cheng S, et al. Does comorbidity explain the ethnic inequalities in cervical cancer survival in New Zealand? A retrospective cohort study. BMC cancer. 2011; 11:132. doi: 10.1186/1471-2407-11-132 PMID: 21486460
26. Li H, Hodgson E, Watson L, Shukla A, Nelson JJ. Comorbidities and Concomitant Medication Use in Men with Prostate Cancer or High Levels of PSA Compared to Matched Controls: A GPRD Analysis. Journal of cancer epidemiology. 2012; 2012:291704. doi: 10.1155/2012/291704 PMID: 22570655
27. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. Journal of clinical epidemiology. 1994; 47(11):1245-51. PMID: 7722560
28. Daskivich TJ, Kwan L, Dash A, Saigal C, Litwin MS. An Age Adjusted Comorbidity Index to Predict Long-Term, Other Cause Mortality in Men with Prostate Cancer. The Journal of urology. 2015; 194 (1):73-8. doi: 10.1016/j.juro.2015.01.081 PMID: 25623745
29. Sarfati D, Hill S, Purdie G, Dennett E, Blakely T. How well does routine hospitalisation data capture information on comorbidity in New Zealand? New Zealand Medical Journal. 2010; 123(1310):50-61. PMID: 20360779
30. Crooks CJ, West J, Card TR. A comparison of the recording of comorbidity in primary and secondary care by using the Charlson Index to predict short-term and long-term survival in a routine linked data cohort. BMJ open. 2015; 5(6):e007974. doi: 10.1136/bmjopen-2015-007974 PMID: 26048212
31. Li B, Evans D, Faris P, Dean S, Quan H. Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases. Bmc Health Serv Res. 2008; 8.
32. Ahern TP, Lash TL, Thwin SS, Silliman RA. Impact of acquired comorbidities on all-cause mortality rates among older breast cancer survivors. Medical care. 2009; 47(1):73-9. doi: 10.1097/MLR. 0b013e318180913c PMID: 19106734
33. Ahn DH, Mehta N, Yorio JT, Xie Y, Yan J, Gerber DE. Influence of medical comorbidities on the presentation and outcomes of stage I-III non-small-cell lung cancer. Clinical lung cancer. 2013; 14(6):644-50. doi: 10.1016/j.cllc.2013.06.009 PMID: 23886797
34. Akushevich I, Kravchenko J, Akushevich L, Ukraintseva S, Arbeev K, Yashin A. Cancer Risk and Behavioral Factors, Comorbidities, and Functional Status in the US Elderly Population. ISRN oncology. 2011; 2011:415790. doi: 10.5402/2011/415790 PMID: 22084731
35. Bang UC, Benfield T, Hyldstrup L, Bendtsen F, Beck Jensen JE. Mortality, cancer, and comorbidities associated with chronic pancreatitis: a Danish nationwide matched-cohort study. Gastroenterology. 2014; 146(4):989-94. doi: 10.1053/j.gastro.2013.12.033 PMID: 24389306
36. Hemmelgarn BR, Manns BJ, Quan H, Ghali WA. Adapting the Charlson Comorbidity index for use in patients with ESRD. Am J Kidney Dis. 2003; 42(1):125-32. PMID: 12830464
37. Lund L, Jacobsen J, Norgaard M, McLaughlin JK, Blot WJ, Borre M, et al. The prognostic impact of comorbidities on renal cancer, 1995 to 2006: a Danish population based study. The Journal of urology. 2009; 182(1):35-40. doi: 10.1016/j.juro.2009.02.136 PMID: 19450859
38. Patterson RE, Flatt SW, Saquib N, Rock CL, Caan BJ, Parker BA, et al. Medical comorbidities predict mortality in women with a history of early stage breast cancer. Breast cancer research and treatment. 2010; 122(3):859-65. doi: 10.1007/s10549-010-0732-3 PMID: 20077000
39. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bulletin of the World Health Organisation. 2007; 85(11):867-72.
40. Shack LG, Rachet B, Williams EM, Northover JM, Coleman MP. Does the timing of comorbidity affect colorectal cancer survival? A population based study. Postgraduate medical journal. 2010; 86 (1012):73-8. doi: 10.1136/pgmj.2009.084566 PMID: 20145054
41. Navid A, Hajibandeh S, Mohan J, Hajibandeh S. Improving the accuracy of HES comorbidity codes by better documentation in surgical admission proforma. British Journal of Hospital Medicine. 2015; 76 (12):707-12. doi: 10.12968/hmed.2015.76.12.707 PMID: 26646333
42. Howlader N, Mariotto AB, Woloshin S, Schwartz LM. Providing clinicians and patients with actual prognosis: cancer in the context of competing causes of death. Journal of the National Cancer Institute Monographs. 2014; 2014(49):255-64. doi: 10.1093/jncimonographs/lgu022 PMID: 25417239
43. Cole SR, Platt RW, Schisterman EF, Chu H, Westreich D, Richardson D, et al. Illustrating bias due to conditioning on a collider. International journal of epidemiology. 2010; 39(2):417-20. doi: 10.1093/ije/dyp334 PMID: 19926667
44. Hatlen P, Grønberg BH, Langhammer A, Carlsen SM, Amundsen T. Prolonged Survival in Patients with Lung Cancer with Diabetes Mellitus. Journal of Thoracic Oncology. 2011; 6(11):1810-7. doi: 10.1097/JTO.0b013e31822a75be PMID: 21964531
45. Braithwaite D, Moore DH, Satariano WA, Kwan ML, Hiatt RA, Kroenke C, et al. Prognostic Impact of Comorbidity among Long-Term Breast Cancer Survivors: Results from the LACE Study. Cancer Epidemiology Biomarkers and Prevention. 2012; 21(7):1115-25.
46. Sarfati D, Hill S, Blakely T, Robson B, Purdie G, Dennett E, et al. The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study. BMC cancer. 2009; 9:116. doi: 10.1186/1471-2407-9-116 PMID: 19379520
47. van Doorn C, Bogardus ST, Williams CS, Concato J, Towle VR, Inouye SK. Risk adjustment for older hospitalized persons: a comparison of two methods of data collection for the Charlson index. Journal of clinical epidemiology. 2001; 54(7):694-701. PMID: 11438410
48. Malenka DJ, McLerran D, Roos N, Fisher ES, Wennberg JE. Using administrative data to describe casemix: a comparison with the medical record. Journal of clinical epidemiology. 1994; 47(9):1027-32. PMID: 7730905
49. Newschaffer CJ, Bush TL, Penberthy LT. Comorbidity measurement in elderly female breast cancer patients with administrative and medical records data. Journal of clinical epidemiology. 1997; 50 (6):725-33. PMID: 9250271